Alzheimer’s disease (AD) is the most common form of dementia, a neurologic disease characterized by loss of mental ability severe enough to interfere with normal activities of daily living, lasting at least six months, and not present from birth. AD usually occurs in old age, and is marked by a decline in cognitive functions such as remembering, reasoning, and planning.
Compared with placebo, the use of G biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. – Older adults who used the herbal supplement Ginkgo biloba for several years did not have a slower rate of cognitive decline compared to adults who received placebo.
Preparing for successful aging — Successful Cognitive and Emotional Aging – It’s never too early or too late to start working toward the goal of improving brain health. So perhaps the New Year is the perfect time to consider how one achieves a long and satisfying life.
Researchers find high leptin levels may protect against Alzheimer’s disease and dementia – Researchers from Boston University School of Medicine (BUSM) have found that higher leptin (a protein that controls weight and appetite) levels were associated with a lower incidence of Alzheimer’s Disease (AD) and dementia.
Green tea chemical combined with another may hold promise for treatment of brain disorders – Researchers have found that combining two chemicals, one of which is the green tea component EGCG, can prevent and destroy a variety of protein structures known as amyloids. Amyloids are the primary culprits in fatal brain disorders such as Alzheimer’s, Huntington’s, and Parkinson’s diseases.
UK Government takes action on antipsychotic drugs and dementia – A tough new action plan to tackle the over prescribing of antipsychotic drugs to people with dementia was announced by Care Services Minister Phil Hope in UK.
Reduced muscle strength associated with risk for Alzheimer’s disease – Individuals with weaker muscles appear to have a higher risk for Alzheimer’s disease and declines in cognitive function over time, revealed by the researchers.
Oleocanthal may help prevent, treat Alzheimer’s disease – Natural compound in extra virgin olive oil targets toxic beta-amyloid proteins. – Natural compound, Oleocanthal, in extra virgin olive oil targets toxic beta amyloid proteins in patients with Alzheimer’s disease, revealed by US researchers. Extra virgin olive oil contains the highest amount of polyphenol antioxidants also.
Sleep loss linked to increase in Alzheimer’s plaques – Neurodegenerative disorders like Alzheimer’s disease and Parkinson’s disease often disrupt sleep. The new researches indicate that sleep loss could play a role in the genesis of such disorders.
Historic gene therapy trial to treat Alzheimer’s disease underway at Georgetown – To stop the progression of Alzheimer’s disease, scientists are conducting gene therapy trial on patients with a mild form of Alzheimer’s Disease in US.
Problems managing money may surface shortly before Alzheimer’s disease sets in – New research finds poor money management skills may indicate that a person with mild memory problems will soon develop Alzheimer’s disease, revealed by researchers in a new research study.
Exercise and Mediterranean-type diet combined associated with lower risk for Alzheimer’s disease — Findings of observational study warrant further research in controlled clinical trial to clarify the role of these and other possible factors contributing to AD risk – Both being more physically active and adhering to a Mediterranean-type diet appears to be associated with reduced Alzheimer’s risk, according to a new report in the August 12, 2009 issue of the Journal of the American Medical Association (JAMA).
St. Jude scientists report flu infection leaves brain more vulnerable later in life — Avian influenza strain primes brain for Parkinson’s disease. – At least one strain of the H5N1 avian influenza virus leaves survivors at significantly increased risk for Parkinson’s disease and possibly other neurological problems later in life, according to new research from St. Jude Children’s Research Hospital.
